Michael P. Ozga, MD¹, Qiuhong Zhao, MS^2*, Naresh Bumma, MD³, Ashley E. Rosko, MD², Abdullah Khan, MBBS, MSc⁴, Srinivas Devarakonda, MD², Elvira Umyarova, MD⁵, Don M. Benson Jr., MD⁶ and Francesca Cottini, MD⁷

¹Comprehensive Cancer Center, The Ohio State University- Comprehensive Cancer Center, Dublin, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁴Department of Internal Medicine - Hematology, The Ohio State University, Columbus, OH
⁵Division of Hematology, The Ohio State University, Columbus, OH
⁶Riney Family Myeloma Center for Research Excellence, The Ohio State University Medical Center, Columbus, OH
⁷Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH

Sosana Delimpasi, MD^1*, Meletios A. Dimopoulos, MD², Jan Straub, MD^3*, Argiris Symeonidis, MD, PhD⁴, Roman Hájek, MD, PhD⁵, Cyrille Touzeau, MD, PhD^6*, Viralkumar K. Bhanderi, MD^7*, Jesus Berdeja, MD⁸, Petr Pavlíček, MD^9*, Jeffrey V. Matous, MD¹⁰, Pawel J. Robak, MD PhD^11*, Kaveri Suryanarayan, MD^12*, Miguel Villareal^12*, Dasha Cherepanov, PhD^12*, Jaydeep K. Srimani^12*, Huilan Yao, PhD^12*, Richard Labotka, MD¹² and Robert Z. Orlowski, MD, PhD¹³

¹Department of Hematology and Bone Marrow Transplantation Unit, General Hospital Evangelismos, Athens, Greece
²Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Internal Medicine - Hematology, University Hospital, Prague, Czech Republic
⁴Department of Hematology, University General Hospital of Patras, Patras, Greece
⁵University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⁶University Hospital Hôtel Dieu, Nantes, France
⁷Florida Cancer Specialists, Tallahassee Cancer Center, Tallahassee, FL
⁸Sarah Cannon Research Institute, Nashville, TN
⁹Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
¹⁰Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, CO
¹¹Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
¹²Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
¹³Departments of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Utkarsh Goel, MBBS^1*, Charalampos Charalampous, MD^1*, Prashant Kapoor, MD¹, Moritz Binder, MD, MPH¹, Francis K. Buadi, MB¹, David Dingli, MD, PhD¹, Angela Dispenzieri, MD¹, Amie Fonder, PA-C^1*, Morie A. Gertz, MD, MACP¹, Wilson I. Gonsalves, MD¹, Suzanne R. Hayman, MD¹, Miriam A. Hobbs, APRN, CNP, DNP^1*, Yi L. Hwa, NP¹, Taxiarchis Kourelis, MD¹, Martha Q. Lacy, MD¹, Nelson Leung, MD^1,2, Yi Lin, MD, PhD¹, Rahma M Warsame, MD¹, Robert A. Kyle, MD³, S. Vincent Rajkumar, MD^1* and Shaji K Kumar, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Karthik Ramasamy¹, Niels Abildgaard, M.D.², Marie-Christiane Vekemans^3*, Barbara Gamberi, MD^4*, Angel Ramírez Payer, MD^5*, Gillian Millar^6*, Annalisa Ansaloni^6*, Margaret Atiba-Davies^6*, David Bernasconi^6*, Torben Plesner⁷ and Sujith Dhanasiri, MPhil, MSc^6*

¹Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom
²Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
³Cliniques Universitaires Saint-Luc, Brussels, Belgium
⁴Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁵Hospital Universitario Central de Asturias, Oviedo, Spain
⁶Bristol Myers Squibb, Boudry, Switzerland
⁷Sygehus Lillebælt, Vejle, Denmark

Rayan Kaedbey, MD¹, Kevin A Hay, MD, MSc, FRCPC², Esther Masih-Khan, PhD^3*, Moustafa Kardjadj, PhD^4*, Arleigh McCurdy, MD, BSc⁵, Michael P. Chu, MD⁶, Victor H Jimenez-Zepeda, MD⁷, Richard Leblanc, MD, FRCPC⁸, Kevin Song, MD, FRCPC⁹, Hira S Mian, MD¹⁰, Martha L Louzada, MD, MSc¹¹, Michael Sebag, MD, PhD¹², Anthony Reiman, MD^13*, Darrell J White, MD¹⁴, Christopher P. Venner, MD, FRCPC¹⁵, Julie Stakiw, MD, FRCPC¹⁶, Rami Kotb, MD, FRCPC¹⁷, Muhammad Aslam, MD^18*, Debra Bergstrom^19*, Engin Gul, BSc, MBA^20* and Donna E. Reece, MD, FRCPC²¹

¹Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Montreal, QC, Canada
²Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
³Princess Margaret Cancer Centre/ University of Toronto, Toronto, ON, CAN
⁴Canadian Myeloma Research Group, Toronto, ON, Canada
⁵Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
⁶Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada
⁷Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
⁸Hopital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
⁹Division of Hematology, University of British Columbia and Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
¹⁰Department of Oncology, McMaster University, Hamilton, ON, Canada
¹¹University of Western Ontario, London Health Sciences Centre, London, ON, Canada
¹²Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹³Oncology, Saint John Regional Hospital, Saint John, NB, CAN
¹⁴Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹⁵BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
¹⁶Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁷Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
¹⁸Allan Blair Cancer Center, Regina, SK, Canada
¹⁹Division of Hematology, Memorial University of Newfoundland, St John’s, Newfoundland and Labrador, Canada, St John's, NF, Canada
²⁰University Health Network-PMH, Concord, ON, Canada
²¹Princess Margaret Cancer Centre, Toronto, ON, Canada

Luca Bertamini, MD^1,2*, Jean-Baptiste Alberge, PhD^1,2,3*, Habib El-Khoury, MD^1,4, David J. Lee, MD^2,3,5,6, Ciara Murphy^1,2*, Grace Fleming, BS^1,2*, Maya I. Davis, BA^1,4*, Jacqueline Perry, MPH^1*, Christian J. Cea-Curry, BS^1,4*, Audrey Pentz, B.Rad(T)^7*, Thulisile Hlubi^7*, Natalie Smyth, MS^8*, D.J. Sakrikar, PhD^9*, Mark C. Perkins, PhD^10*, Stephen Harding, PhD¹⁰, Derek Troske, BS^9*, Gad Getz, PhD^3*, Timothy R. Rebbeck, PhD^1,11*, Maureen Joffe, PhD^7*, Catherine R. Marinac, PhD^1,11, Nelson Leung, MD^12,13, Carl Wenlong Chen, PhD^7,14,15* and Irene Ghobrial, MD^1,4,16

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³Broad Institute of MIT and Harvard, Cambridge, MA
⁴Department of Medicine, Harvard Medical School, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
⁶Department of Medicine, Massachusetts General Hospital, Boston, MA
⁷Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa
⁸Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
⁹The Binding Site Inc., Rochester, MN
¹⁰The Binding Site Inc., Birmingham, United Kingdom
¹¹Harvard T.H. Chan School of Public Health, Boston, MA
¹²Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
¹³Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
¹⁴National Health Laboratory Service, National Cancer Registry, Johannesburg, South Africa
¹⁵Faculty of Health Sciences, University of the Witwatersrand, Sydney Brenner Institute for Molecular Bioscience, Johannesburg, South Africa
¹⁶The Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA

Sarah Zhao^1*, Cameron Wellard, PhD^2*, Zoe McQuilten, MBBS, PhD^2*, Elizabeth M. Moore, PhD^3*, Erica M. Wood, MBBS, FRACP, FRCPA⁴, Andrew Spencer⁵ and Henry Chan⁶

¹Waitemata DHB, North Shore Hospital, Auckland, New Zealand
²School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
³Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁴Monash Haematology, Monash Health, Clayton, VIC, Australia
⁵Monash University, Melbourne, Australia
⁶Department of Haematology, Waitemata DHB, North Shore Hospital, Auckland, New Zealand

Brian G.M. Durie, MD¹, Annette Lam^2*, Mai Ngo^3*, Huiling Pei, PhD^3* and Eric M. Ammann^2*

¹Cedars-Sinai Oschin Cancer Center, Los Angeles, CA
²Janssen Global Market Access, Raritan
³Janssen Global Medical Affairs Statistics, Raritan

Jingyu Xu^1*, Lingna Li^1*, Wenqiang Yan^1*, Huishou Fan^1*, Jiahui Liu^2*, Chenxing Du, MD^3*, Shuhui Deng, MD^4*, Weiwei Sui^4*, Yan Xu, MD^2*, Lugui Qiu¹ and Gang An, MD^5*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, TIANJIN, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Duoduo Zhao¹, Christian Rohde, PhD^1*, Fengbiao Zhou, PhD^1*, Anna Luise Grab, PhD^1*, Alexandra M Poos, PhD^1*, Lukas John, MD^1*, Stefanie Huhn, PhD^1*, Marc S Raab, MD^1*, Carsten Mueller-Tidow, MD¹ and Niels Weinhold, PhD^2*

¹Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
²Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

Yuan Xia, MD^*, Run Zhang, MD^*, Yuanyuan Jin, MD^*, Qinglin Shi, MBBS^*, Yujie Wu, MD^*, Jianyong Li, MD and Lijuan Chen^*

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Saurabh Zanwar, MBBS^1*, Matthew Ho, MBBCh, BAO, PhD^2*, Francis K. Buadi, MB³, Sikander Ailawadhi⁴, Jeremy T. Larsen^5*, P. Leif Bergsagel, MD⁶, Moritz Binder, MD¹, Asher Chanan-Khan, MD⁷, David Dingli, MD, PhD¹, Angela Dispenzieri, MD⁸, Rafael Fonseca, MD⁹, Morie A. Gertz, MD, MACP⁸, Wilson I. Gonsalves, MD¹⁰, Ronald Go, MD¹, Suzanne R. Hayman, MD¹, Prashant Kapoor, MD¹¹, Taxiarchis Kourelis, MD¹, Martha Q. Lacy, MD¹², Nelson Leung, MD¹³, Yi Lin, MD, PhD¹¹, Eli Muchtar, MD¹⁴, Vivek Roy, MD¹⁵, Taimur Sher, MD¹⁶, Rahma M Warsame, MD¹¹, Amie Fonder, PA-C^1*, Miriam A. Hobbs, APRN, CNP, DNP^1*, Yi L. Hwa, NP¹, Robert A. Kyle, MD¹⁷, S. Vincent Rajkumar, MD^1* and Shaji K Kumar, MD¹¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Internal Medicine, Mayo Clinic, Rochester, MN
³Mayo clinic college of medicine, Rochester, MN
⁴Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
⁵Division of Hematology, Mayo Clinic, Phoenix, AZ
⁶Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
⁷Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁸Mayo Clinic, Rochester, MN
⁹Department of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
¹⁰Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
¹¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
¹²Division of Hematology, Mayo Clinic Rochester, Rochester, MN
¹³Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
¹⁴Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
¹⁵Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
¹⁶Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
¹⁷Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Alexander Leipold^1*, Rudolf Werner^2*, Johannes Duell, MD^3,4*, Pius Jung^5*, Mara John^6*, Emilia Stanojkovska^7*, Xiang Zhou^8,9*, Anna Ruckdeschel, MD^10*, Oliver Dietrich^11*, Fabian Imdahl^11*, Tobias Krammer^11*, Andreas Buck, MD^12*, Julia Mersi, MD^13*, Hermann Einsele, MD^13,14, K. Martin Kortuem^13,15*, Antoine-Emmanuel Saliba^11* and Leo Rasche, MD^16*

¹Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, Germany
²Klinik und Poliklinik für Nuklearmedizin, University Hospital of Würzburg, Würzburg, Germany
³Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Bavaria, Germany
⁴Department of Internal Medicine II, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
⁵University Hospital of Würzburg, Würzburg, Germany
⁶Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, DEU
⁷Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, DEU
⁸Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany
⁹Department of Internal Medicine II, Division of Oncology and Hematology, Würzburg University Hospital, Würzburg, Germany
¹⁰University Hospital Würzburg, Würzburg, DEU
¹¹Helmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany
¹²Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany
¹³Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
¹⁴Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
¹⁵Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
¹⁶Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Bayern, Germany

Nikhil Grandhi^1*, Lawrence Liu, MD^2*, Mei Wang^3*, Theodore S. Thomas, MD, MPHS⁴, Kristen M. Sanfilippo, MD⁵, Feng Gao, MD, PhD, MPH^6*, Graham A Colditz, MD, DrPH^7* and Su-Hsin Chang, PhD^8*

¹Washington University in St. Louis, Saint Louis, MO
²City of Hope National Medical Center, Duarte, CA
³Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, MO
⁴St. Louis Veterans Affairs Medical Center, Saint Louis, MO
⁵Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
⁶Public Health Sciences Division, Washington University School of Medicine, St. Louis, MO
⁷Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St Louis, MO
⁸Research Service, St. Louis Veterans Affairs Medical Center, Saint Louis, MO

Sæmundur Rögnvaldsson, MD^1,2*, Jon Þórir Oskarsson, MSc^3*, Sigrun Thorsteinsdottir, MD, PhD^4,5, Elin Ruth Reed^4*, Gudrun Asta Sigurdardottir^4*, Brynjar Vidarsson, MD², Pall Torfi Onundarson, MD², Margret Sigurdardottir, MD^2*, Bjarni Agnar Agnarsson, MD^2*, Isleifur Olafsson, MD, PhD^2*, Ingunn Thorsteinsdottir, MD^2*, Signy Vala Sveinsdottir, MD PhD^2*, Robert Palmason^4,6*, Fridbjorn Sigurdsson, MD^7*, Asdis Rosa Thordardottir^4*, Elias Eythorsson, MD, PhD^8*, Asbjorn Jonsson, MD^7*, Runolfur Palsson, MD^2,4*, Olafur Skuli Indridason, MD, MHS^2*, Thor Aspelund, PhD^4*, Gauti Gislason^4*, Andri Olafsson^4*, Jon Kristinn Sigurdsson^4*, Ingigerdur S Sverrisdottir, MD^9*, Gudlaug Katrin Hakonardottir^4*, Thorir Einarsson Long, MD, PhD^6,10*, Ragnar Danielsen, MD^2*, Malin Hultcrantz, MD, PhD¹¹, Brian G.M. Durie, MD¹², Stephen Harding, PhD¹³, Ola Landgren, MD¹⁴, Thorvardur Jon Love, MD, PhD^2,4* and Sigurdur Y Kristinsson, MD, PhD^2,4

¹Faculty of Medicine, University of Iceland, Reykjavík, Iceland
²Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
³Faculty of Medicine, University of Iceland, Reykjavik, Reykjavik, Iceland
⁴Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁵Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
⁶Skåne University Hospital, Lund, Sweden
⁷Akureyri Hospital, Akureyri, Iceland
⁸Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland
⁹Sahlgrenska University Hospital, Gothenburg, Sweden
¹⁰Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
¹¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
¹³The Binding Site Inc., Birmingham, United Kingdom
¹⁴Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Massimo Offidani, MD¹, Carmela Zizzo^2*, Serena Rupoli, MD^3*, Irene Federici^4*, Sonia Morè^5*, Alessandra Bossi^6*, Valentina Maria Manieri^5*, Maria Teresa Petrucci, MD⁷, Tommaso Caravita DI Toritto, MD, PhD^8*, Marino Brunori^9*, Alessandro Gozzetti^10*, Attilio Tordi^11*, Francesca Fazio^12*, Chiara Lisi, MD^13*, Assunta Melaccio^14*, Lucia Ciuffreda^15*, Antonietta Pia Falcone^16*, Francesca Fioritoni, MD^17*, Silvia Gentili, MD^18*, Agostina Siniscalchi^19*, Fabio Trastulli, MD^20*, Laura Corvatta, MD^21*, Erika Morsia, MD^22*, Attilio Olivieri, MD^23* and Giovanni Duro^2*

¹Hematology Clinic, AOU Ospedali Riuniti di Ancona, Ancona, Italy
²Institute for Research and Biomedical Innovation (IRIB) of the National Research Council of Italy (CNR), Palermo, Italy
³Clinic of Hematology, Ospedali Riuniti di Ancona, Ancona, Italy
⁴Ospedali Riuniti Ancona, Ancona, ITA
⁵Hematology Clinic, AOU Ospedali Riuniti Ancona, Ancona, Italy
⁶AOU Ospedali Riuniti di Ancona, Ancona, Italy
⁷Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
⁸UOSD Ematologia ASL Roma 1, Roma, MARSEILLE CEDEX 09, Italy
⁹Internal Medicine, Ospedale S. Croce, Azienda Ospedaliera Ospedali Riuniti Marche Nord, FANO, ITA
¹⁰Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy
¹¹Ospedale Santo Spirito- ASL Roma1, Roma, Italy
¹²Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Italy, ROMA, Italy
¹³Ospedale Policlinico Umberto I, Roma, Italy
¹⁴Department of Biomedical Sciences and Human Oncology, Unit of Internal Medicine “Guido Baccelli”, University of Bari Aldo Moro Medical School, University of Bari Medical School, Bari, Italy
¹⁵Ospedale Cisanello di Foggia, Foggia, Italy
¹⁶Unità di Ematologia, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
¹⁷Department of Hematology, Transfusion Medicine and Biotechnology, "Santo Spirito" Civic Hospital, Pescara, Italy
¹⁸Hematology Unit, Ospedale Generale di Civitanova Marche, Civitanova Marche, Italy
¹⁹UOSD San Filippo Neri, Roma, Italy
²⁰Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
²¹Ospedale E. Profili Fabriano, Fabriano, Italy
²²Ospedali Riuniti di Ancona, Clinic of Hematology, Ancona, Italy
²³Università Politecnica Delle Marche, Ancona, Italy

Alankrita Taneja, MBBS¹, Katy Wang, M.A.^1*, Sarah Parker^1*, Sheeba Ba Aqeel, MD¹, Joseph D. Tario Jr., PhD^2*, Hassan Awada, MD^1*, Arya Roy, MD^1*, Maximilian Merz, MD³, Philip L. McCarthy, MD¹ and Jens Hillengass, MD, PhD¹

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

Ingigerdur S Sverrisdottir, MD^1,2*, Sigrún Thorsteinsdóttir, MD, PhD^2,3, Sæmundur Rögnvaldsson, MD^4*, Thor Aspelund, PhD^2*, Brynjar Vidarsson, MD⁵, Páll Torfi Önundarson, MD^5*, Bjarni Agnarsson, MD^5*, Margrét Sigurdardóttir, MD^5*, Ingunn Thorsteinsdottir, MD^5*, Signy Vala Sveinsdottir, MD PhD^5*, Robert Palmason^2,6*, Ísleifur Ólafsson, MD, PhD^5*, Fridbjorn Sigurdsson, MD^5*, Ásdis Rósa Thórdardottir^2*, Elias Eythorsson, MD, PhD^5*, Asbjorn Jonsson, MD^5*, Runolfur Palsson, MD^2,5*, Olafur Skuli Indridason, MD, MHS^2,5*, Gauti Kjartan Gislason, MSc^2*, Andri Olafsson^2*, Jon Kristinn Sigurdsson^2*, Hlif Steingrimsdottir, MD^5*, Thorir Einarsson Long, MD, PhD^2,6*, Malin Hultcrantz, MD, PhD⁷, Brian G.M. Durie, MD⁸, Stephen Harding, PhD⁹, Ola Landgren, MD¹⁰, Sigurdur Y Kristinsson, MD, PhD^2,5 and Thorvardur Jon Love, MD, PhD^2,5*

¹Sahlgrenska University Hospital, Gothenburg, Sweden
²Faculty of Medicine, University of Iceland, Reykjavik, Iceland
³Rigshospitalet, Copenhagen, Denmark
⁴Faculty of Medicine, University of Iceland, Reykjavík, Iceland
⁵Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
⁶Skåne University Hospital, Lund, Sweden
⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
⁹The Binding Site Inc., Birmingham, United Kingdom
¹⁰Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Salyka M. Sengsayadeth, MD^1*, Bridget Fitzgerald^2*, Bharat Nandakumar^3*, Bicky Thapa, MD^4*, Timothy Martin Schmidt, MD⁵, Rebecca Silbermann, MD, MMS⁶, Heidi Chen, PhD^7*, Saurabh Chhabra, MD, MS⁸, Natalie Callander, MD⁹, Shaji K Kumar, MD¹⁰ and Luciano J. Megala Costa, MD, PhD¹¹

¹Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
²Vanderbilt University Medical Center, Nashville, TN
³Mayo Clinic, Rochester, MN
⁴Medical College of Wisconsin, Milwaukee, WI
⁵University of Wisconsin Carbone Cancer Center, Madison, WI
⁶School of Medicine Oregon Health and Science University, Portland, OR
⁷Vanderbilt Ingram Cancer Center, Nashville, TN
⁸Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁹University of Wisconsin, Madison, WI
¹⁰Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
¹¹University of Alabama at Birmingham Hospital, Vestavia, AL

Sheena Sharma^1,2*, Diane Wang^1*, Hoi-Kei Lon^1*, Pooneh Soltantabar^1*, Andrea Viqueira, MD^3*, Akos Czibere^4*, Anne Hickman^5*, Jane Liang White, ScD^4* and Mohamed Elmeliegy, PhD^1*

¹Global Product Development, Pfizer Inc, San Diego, CA
²Department of Pharmaceutical Sciences, Washington State University, Spokane, WA
³Pfizer SLU, Madrid, Spain
⁴Global Product Development, Pfizer Inc, Cambridge, MA
⁵Global Product Development, Pfizer Inc, Groton, CT

John D Cooper, MD^1*, Jennifer A Thornton, PhD^2*, Steven J Gibson, MD^3*, Kevin Pham^4*, Kevin Sunderland^4* and Christin B DeStefano, MD⁵

¹Walter Reed National Military Medical Center, Bethesda, MD
²Clinical Investigation Facility, David Grant USAF Medical Center, Fairfield, CA
³Internal Medicine Residency Program, National Capital Consortium, Bethesda, MD
⁴David Grant USAF Medical Center, Fairfield, CA
⁵Hematology/Oncology, Walter Reed National Military Medical Center, Bethesda, MD

Ayrton Bangolo^1*, Samir Oza, MBS, BS^2*, Ronit Slotky, PhD, MSc^2*, Aimee Chappell^3*, David Samuel Siegel, MD, PhD^{4,5,6,7,8,9,10,11}, Harsh Parmar, MD^12*, Noa Biran, MD^{6,13,14,15,16}, David H. Vesole, MD, PhD¹⁷ and Pooja Phull, MD²

¹Hackensack Meridian Health/Palisades Medical Center, Edgewater, NJ
²John Theurer Cancer Center/Hackensack University Medical Center, Hackensack, NJ
³Medstar Georgetown University Hospital Department of Hematology/Oncology, Washington
⁴Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health and Center for Discovery and Innovation, Hackensack, NJ
⁵Hackensack University John Theurer Cancer Center, Hackensack, NJ
⁶John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁷John Theurer Cancer Center, Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ
⁸111 Ideation Way, Center for Discovery & Innovation, Nutley, NJ
⁹Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁰John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
¹¹Hackensack University Medical Center, Hackensack, NJ
¹²Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ
¹³Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
¹⁴John Theurer Cancer Center, Hackensack Meridian Health, Division of Multiple Myeloma, Hackensack, NJ
¹⁵John Therurer Cancer Center at Hackensack University, Hackensack, NJ
¹⁶Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Tenafly, NJ
¹⁷Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ, Hackensack, NJ

Anup Joseph Devasia, MD, DM^1*, Sahar Khan, FRCPath, MD^2*, Harminder K Paul, MSc^3*, Frédéric Larose, MD^4*, Eshetu G. Atenafu, M.Sc., P.Stat^5,6*, Donna E. Reece, MD, FRCPC⁷, Suzanne Trudel, MD^7*, A. Keith Stewart, MBChB⁸, Sita Bhella, M.D., MSc^3*, Vishal Kukreti, MD, FRCP, MSc⁹, Chloe Yang, MD^3*, Rodger E Tiedemann, MBChB, PhD⁸, Anca Prica, MD, MSc^10*, Monica Monchis^7*, Eugene Leung^7*, Susan Jomah^7*, Zubaida Mohamed^7* and Christine Chen, MHPE, MD, FRCPC^11*

¹Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Windsor Regional Cancer Centre, Windsor, ON, CAN
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
⁴Hotel-Dieu-de-Levis hospital, Québec, QC, Canada
⁵Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹University Health Network, Princess Margaret Hospital, Toronto, ON, Canada
¹⁰University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
¹¹Princess Margaret Cancer Center, Toronto, Canada

Anas Al Zubaidi, MD^1*, Abdul Rahman Al Armashi, MD^2*, Dina Elantably, MD^3*, Jiasheng Wang, MD² and Akram Alkrekshi, MD^4*

¹Johns Hopkins University, Baltimore, MD
²Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
³Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Cleveland, OH
⁴Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Westlake, OH

Pierre-Edouard Debureaux, MD^1*, Stephanie Harel, MD^1*, Nathalie Parquet, MD^2*, Virginie Lemiale, MD^3*, Virginie Siguret, PhD^4*, Laurie Goubeau^4*, Florence Morin, MD^5*, Bruno Royer, MD^1*, Wendy Cuccuini, MD, PhD^6*, Dikelele Elessa, MD^1*, Floriane Theves, MD^1*, Anne Brignier, MD^2*, Elie Azoulay, MD PhD^3,7*, Bertrand Arnulf^7,8* and Alexis Talbot, MD^1,7*

¹Immuno-Hematology, Saint Louis Hospital, Paris, France
²Therapeutic Apheresis Unit, Saint Louis Hospital, Paris, France
³ICU Unit, Saint Louis Hospital, Paris, France
⁴Hematology Laboratory, Lariboisière Hospital, Paris, France
⁵Laboratory of Immunology, Saint Louis Hospital, APHP, University of Paris, Paris, France, Paris, France
⁶Hematology Laboratory APHP and INSERM U944, Saint Louis Hospital, PARIS, FRA
⁷University of Paris Cité, Paris, France
⁸Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France

Ping Zhou, MD, PhD^1*, Mahesh M Mansukhani, MD^2*, Denis Toskic, BS^3*, Stephanie Scalia, MS^3*, Lisa Lee, MD^4*, Sandy W. Wong, MD⁵, Sascha A. Tuchman, MD, MHS⁶, James E. Hoffman, MD^7*, Teresa Fogaren, NP^1*, Cindy Varga, MD, BSc⁸, Suzanne Lentzsch, MD, PhD^9* and Raymond Comenzo, MD¹

¹Tufts Medical Center, Boston, MA
²Columbia University Medical Center, New York, NY
³John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
⁴Chao Family Comprehensive Cancer Center, UC Irvine, Orange, CA
⁵Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
⁶Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁷Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁸Levine Cancer Institute, Charlotte, NC
⁹Medical Oncology, Columbia University Medical Center, New York, NY

Gary J. Schiller, MD¹, Sascha A. Tuchman, MD, MHS², Natalie Callander, MD³, Muhamed Baljevic, MD⁴, Adrianna C Rossi, MD^5*, Rami Kotb, MD, FRCPC⁶, Darrell J White, MD⁷, Nizar J. Bahlis, MD⁸, Heather J. Sutherland, MD, PhD, FRCPC⁹, Sumit Madan, MD¹⁰, Richard Leblanc, MD, FRCPC¹¹, Christopher P. Venner, MD¹², William I. Bensinger, MD^13*, Dane R. Van Domelen, PhD^14*, Chris Zhang, MD^14*, Ohad S. Bentur, MD MHA¹⁴ and Brea Lipe, MD¹⁵

¹UCLA David Geffen School of Medicine, Los Angeles, CA
²University of North Carolina, Chapel Hill, NC
³University of Wisconsin Carbone Cancer Center, Madison, WI
⁴University of Nebraska Medical Center, Omaha, NE
⁵NYPH Weill Cornell, New York, NY
⁶Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
⁷Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁸Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁹Division of Hematology, Vancouver General Hospital, Vancouver, BC, Canada
¹⁰Banner MD Anderson Cancer Center at Banner University Medical Center, Phoenix, AZ
¹¹Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
¹²University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
¹³Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹⁴Karyopharm Therapeutics Inc., Newton, MA
¹⁵The Department of Medicine, University of Rochester Medical Center, Rochester, NY

Jing Dong, PhD¹, Jian-Rong Li, phD^2*, Christopher Staffi Buradagunta, MS^3*, Siegfried Janz¹, Raul Urrutia, MD^4* and Chao Cheng^2,5*

¹Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Medicine, Baylor College of Medicine, Houston, TX
³Medicine, MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
⁴Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI
⁵Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX

Hongying You, MD^1*, Song Jin, MD, PhD^1*, Chunxiao Wu, MD^1*, Qingqing Wang, MD^1*, Shuang Yan, MD^1*, Yingying Zhai, MD^1*, Weiqin Yao, MD^1*, Xiaolan Shi, MD, PhD^1*, Jingjing Shang, MD, PhD^1*, Lingzhi Yan, MD, PhD^2*, Ying Yao, MD^3*, Jing Wang, MD^3*, Panfeng Wang, MD^3*, Jinlan Pan, MD^1*, Depei Wu¹ and Chengcheng Fu, MD, PhD^1*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
³Soochow Hopes Hematonosis Hospital, Suzhou, China

Katie Dunphy^1*, Despina Bazou, BSc, MSc, PhD^2*, Paul Dowling, BSc, PhD^1* and Peter O'Gorman, MD, PhD, FRCP, FRCPath²

¹Biology Department, Maynooth University, Co. Kildare, Ireland
²Department of Hematology, Mater Misericordiae University Hospital, Dublin 7, Ireland

Naseem S Esteghamat, MD¹, Ann M Brunson, MS^2*, Ted Wun, MD³, Aaron S Rosenberg, MD¹, Julianne J.P. Cooley, MS^4*, Sara J. Schonfeld^5*, Christa L. Meyer, MS^6*, Bryan Valcarcel, MD^5*, Renata Abrahao, MD, PhD, MSc⁷, Jeffery Auletta, MD^8,9, Lindsay M. Morton, PhD⁵, Lori Muffly, MD¹⁰ and Theresa H.M. Keegan, PhD⁷

¹Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
²Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
³UC Davis Comprehensive Cancer Center, Sacramento, CA
⁴California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁵Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
⁶CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
⁷Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁸Center for International Bone Marrow Transplant Registry/National Marrow Donor Program/Be the Match, Minneapolis, MN
⁹Nationwide Children's Hospital, Columbus, OH
¹⁰Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA

Ben Massat, DO^1*, Gokul Pareek^2*, Christopher Staffi Buradagunta^2*, Bicky Thapa, MD^3*, Paul Auer, phD^4*, Binod Dhakal, MBBS⁵, Siegfried Janz⁶, Parameswaran Hari, MD, MRCP³ and Jing Dong, PhD⁶

¹Medicine, Medical College of Wisconsin, Milwaukee, WI
²MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
³Medical College of Wisconsin, Milwaukee, WI
⁴Division of Biostatistics, Institute for Health & Equity, and Cancer Center, MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
⁵Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁶Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

W. Cliff Rutter, PharmD, PhD^1*, Elisea Avalos-Reyes, PhD^1*, Will Cavers, MSc^1*, Shivaani Prakash, MSc, PhD^1*, Kjel Johnson, PharmD^1* and Leon Bernal-Mizrachi, MD²

¹CVS Health, Lincoln, RI
²Winship Cancer Institute/Department of Hematology and Medical Oncology, Emory University, Brookhaven, GA

Andrea Angioi, MD^1*, Moritz Binder, MD², Nelson Leung, MD^3,4, Frank Bridoux, MD, PhD^5*, Camille Cohen^6*, David Dingli, MD, PhD², Angela Dispenzieri, MD², Parikshit Duriseti, MD^3*, Roberta Fenoglio^7*, Amie Fonder, PA-C^2*, Morie A. Gertz, MD, MACP², Ronald Go, MD², Wilson I. Gonsalves, MD², Suzanne R. Hayman, MD², Miriam A. Hobbs, APRN, CNP, DNP^2*, Yi L. Hwa, NP², Prashant Kapoor, MD², Bertrand Knebelmann^8*, Taxiarchis Kourelis, MD², Shaji K Kumar, MD², Robert A. Kyle, MD⁹, Martha Q. Lacy, MD¹⁰, Nicola Lepori^1*, Yi Lin, MD, PhD², Shveta Motwani, MD^11*, Eli Muchtar, MD², Samih Nasr, MD^12*, Antonello Pani^13*, Dario Roccatello^14*, Virginie Royal, MD^15*, Paul Sanders^16*, Stephan Troyanov, MD^17*, Christopher P. Venner^18*, Rahma M Warsame, MD², Niloufarsadat Yarandi, MD^19* and S. Vincent Rajkumar, MD^2*

¹Azienda Ospedaliera G. Brotzu, Cagliari, ITA
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
⁵Nephrology and Transplant Unit, CHU Poitiers, Poitiers, France
⁶Necker Hospital, Paris, FRA
⁷S. Giovanni Bosco Hospital and University of Turin, Turino, ITA
⁸Service de Néphrologie, Necker hospital, Paris, France
⁹Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN
¹⁰Division of Hematology, Mayo Clinic Rochester, Rochester, MN
¹¹Division of Nephrology, Dana Farber Cancer Institute, Boston, MA
¹²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹³Divisione di Nefrologia e Dialisi, Azienda Ospedaliera G. Brotzu, Cagliari, ITA
¹⁴Nephrology and Dialysis Unit, S. Giovanni Bosco Hospital and University of Turin, Turin, ITA
¹⁵Division of Pathology, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, QC, CAN
¹⁶University of Alabama At Birmingham, Birmingham, AL
¹⁷Division of Nephrology, Hôpital du Sacré-Cœur, Université de Montréal, Montreal, QC, Canada
¹⁸Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹⁹Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, CT

Zhengyu Yu, PhD^1*, Linfeng Li^2*, Jin Xu, PhD^1*, Hui Zhou, PhD^1* and Ting Niu^1,3

¹Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China
²Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
³State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Guido Lancman, MD, MSc^1,2, Kian Parsa, DO^3*, Cesar Rodriguez, MD¹, Joshua Richter, MD¹, Hearn J. Cho, MD, PhD¹, Samir Parekh, MD¹, Shambavi Richard, MD¹, Adriana Rossi, MD, MSc¹, Larysa Sanchez, MD¹, Santiago Thibaud, MD¹, Sundar Jagannath¹ and Ajai Chari, MD¹

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Icahn School of Medicine at Mount Sinai, New York, NY

Dr. Maryam Alomran, MD^1*, Cameron Wellard, PhD^2*, Pin-Yen Chen, BBiomedSc (Hons), PhD^3*, Elizabeth M. Moore, PhD^3* and Wee Joo Chng, MBChB PhD⁴

¹Hematology, NUH singapore, Salmaniya, AL, Bahrain
²School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
³Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁴National University Cancer Institute, Singapore, Singapore

Timothy Martin Schmidt, MD¹, Rebecca Silbermann, MD, MMS², Susan Bal, MD³, Binod Dhakal, MBBS⁴, Bhagirathbhai Dholaria, MBBS⁵, Eden Biltibo, MD, MS⁶, Saurabh Chhabra, MD, MS⁷, Smith Giri, MD, MHS⁸, Kelly N. Godby, MD^9*, Sonia Gowda, MD^10*, Eva Medvedova, MD², Natalie Callander, MD¹¹ and Luciano J. Megala Costa, MD, PhD³

¹Carbone Cancer Center, University of Wisconsin, Madison, WI
²Knight Cancer Institute, Oregon Health and Science University, Portland, OR
³University of Alabama at Birmingham, Birmingham, AL
⁴Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁵Vanderbilt University Medical Center and Vanderbilt- Ingram Cancer Center, Nashville, TN
⁶Vanderbilt University Medical Center, Nashville, TN
⁷Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁹Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
¹⁰Department of Internal Medicine, Oregon Health and Science University, Portland, OR
¹¹University of Wisconsin Carbone Cancer Center, Madison, WI

Andrew Gahagan, MD¹, Sunil Rangarajan, MD, MBBS², Clare Ubersax, BS^3*, Abigail Tucker, MSPH^3*, Christian Harmon, MD^3*, Monica Sai Pasala, BS^4*, Susan Bal, MD⁵, Kelly N. Godby, MD^6*, Gayathri Ravi, MD⁶, Luciano J. Megala Costa, MD, PhD⁷, Grant Williams, MD, MPH^2*, Smita Bhatia, MD, MPH³ and Smith Giri, MD, MHS³

¹University of Alabama at Birmingham Hospital, Birmingham, AL
²Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
³Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁴School of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁵University of Alabama at Birmingham, Birmingham, AL
⁶Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁷University of Alabama at Birmingham Hospital, Vestavia, AL

Brian Hoeynck, MD¹, Wei-Ting Hwang^2*, Alfred L Garfall, MD³, Sandra Patricia Susanibar-Adaniya, MD^3*, Dan T. Vogl, MD³, Adam Waxman, MD³, Edward A. Stadtmauer, MD³ and Adam D Cohen, MD⁴

¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
²Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
³Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴University of Pennsylvania, Philadelphia, PA

Luciano J. Megala Costa, MD, PhD¹, Kelly N. Godby, MD^2*, Gayathri Ravi, MD^3*, Smith Giri, MD, MHS⁴ and Susan Bal, MD⁵

¹University of Alabama at Birmingham Hospital, Vestavia, AL
²Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
³Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL
⁴Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁵University of Alabama at Birmingham, Birmingham, AL

Murielle Roussel, MD^1,2,3*, Michelle Pirotte, MD^1,4,5*, Ornella Rizzo, MD^1,4,6*, Kentin Queru^1,4*, Thomas Chalopin, MD^7*, Olivier Decaux, MD, PhD^8,9*, Estelle Desport, MD^10,11*, Frank Bridoux, MD, PhD^3,10,11* and Arnaud Jaccard^1,3,4*

¹CHU of Limoges and Poitiers, French National Reference Center for AL amyloidosis and monoclonal immunoglobulin deposition diseases, Limoges, France
²CHU Dupuytren, Department of Hematology and Cellular Therapy, Limoges Cedex 1, France
³CRIBL Lab, UMR CNRS 7276, INSERM U1262, Limoges, France
⁴CHU Dupuytren, Department of Hematology and Cellular Therapy, Limoges, France
⁵Department of Hematology, CHU Sart-Tilman and University of Liège, Liège, Belgium
⁶Brussels, Brussels, BEL
⁷Department of Hematology and Cellular Therapy, Tours University Hospital, UMR CNRS, François Rabelais University, Tours, France
⁸Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
⁹Université de Rennes 1, INSERM, Établissement Français du Sang de Bretagne, Unité Mixte de Recherche (UMR)_S1236, Rennes, France
¹⁰Nephrology and Transplant Unit, CHU Poitiers, Poitiers, France
¹¹CHU of Limoges and Poitiers, French National Reference Center for AL amyloidosis and monoclonal immunoglobulin deposition diseases, Poitiers, France

Limei Zhang^1*, Yun Wang, MD, PhD^2*, Robert Peter Gale³ and Yang Liang, MD, PhD²

¹Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
²State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
³Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

Medha Reddy Cherabuddi, MBBS^1*, Kathren Shango, MD^1*, Swetha Reddi, BS^1*, Pin Li, PhD^2* and Vijaya Donthireddy, MD³

¹Internal Medicine, Henry Ford Hospital, Detroit, MI
²Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI
³Hematology and Oncology, Henry Ford Hospital, Detroit, MI

Jeremy A. Ross, PhD^1*, Herve Avet-Loiseau, MD, PhD^2*, Xiaotong Li, PhD^3*, Raphaele Thiebaut-Millot, PhD^3* and Carlos Hader, PhD^1*

¹AbbVie, Inc., North Chicago, IL
²Universite Paul Sabatier, Toulouse, FRA
³AbbVie Inc., North Chicago, IL

Andrew R. Branagan, MD¹, Matthew M Lei, PharmD^1*, Clifton C Mo, MD^2*, Andrew J. Yee, MD¹, Elizabeth K. O'Donnell, MD¹, Jorge J. Castillo, MD², Omar Nadeem, MD³, Noopur Raje, MD¹, Steven P Treon, MD, PhD², Paul G. Richardson, MD², Rie Nakamoto-Matsubara, MD, PhD^1*, Kirsten Meid, MPH^2*, Zachary S. Bernstein^1*, Rebecca T. Lyons^1*, Rakesh Verma, PhD^1*, Zachary R Hunter, PhD², Maria Luisa Guerrera, MD², Catherine A. Flynn, NP^2*, Jill N. Burke, NP^1*, Cynthia C. Harrington, NP^1*, Emerentia Agyemang, NP^1*, Marilyn T. Gammon, RN^1*, Kathleen J. Lively, RN^1*, Lisette Packer, RN^1*, Nora K. Horick, MS^1* and Shayna Sarosiek, MD⁴

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

Wenjing Wang, MD^*, Jing Li, MD^*, Yang Yang, MD^*, Feifei Chen, MD, PhD^*, Tianhong Xu, MD^*, Pu Wang^*, Yawen Wang^*, Aziguli Maihemaiti^*, Liang Ren^* and Peng Liu, MD

Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China

Ástrún Helga Jónsdóttir^1*, Sæmundur Rögnvaldsson, MD^1,2*, Helga Ágústa Sigurjónsdóttir^2,3*, Sigrún Thorsteinsdóttir, MD, PhD^3,4, Brynjar Vidarsson, MD², Páll Torfi Onundarson, MD^2,3, Bjarni Agnarsson, MD^2,3*, Margrét Sigurdardóttir, MD^2*, Ingunn Thorsteinsdóttir, MD, PhD^2*, Ísleifur Ólafsson, MD, PhD^2*, Signy Vala Sveinsdottir, MD^2*, Robert Palmason^2,5*, Ásdis Rósa Thórdardottir^3*, Elias Eythorsson, MD, PhD^2*, Asbjorn Jonsson, MD^2,6*, Runolfur Palsson, MD^2,3*, Olafur Skuli Indridason, MD, MHS^2,3*, Gauti Kjartan Gislason, MSc^3*, Andri Olafsson^3*, Jon Kristinn Sigurdsson^3*, Ingigerdur S Sverrisdottir, MD^2,3,7*, Thorir Einarsson Long, MD, PhD^3,5*, Thor Aspelund, PhD^3*, Malin Hultcrantz, MD, PhD⁸, Brian G.M. Durie, MD⁹, Stephen Harding, PhD¹⁰, Ola Landgren, MD¹¹, Thorvardur Jon Love, MD, PhD^2,3* and Sigurdur Y Kristinsson, MD, PhD^2,3

¹Faculty of Medicine, University of Iceland, Reykjavík, Iceland
²Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
³Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁴Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
⁵Skåne University Hospital, Lund, Sweden
⁶Akureyri Hospital, Akureyri, Iceland
⁷Sahlgrenska University Hospital, Gothenburg, Sweden
⁸Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sloan Kettering Cancer Center, New York, NY
⁹Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
¹⁰The Binding Site Inc., Birmingham, United Kingdom
¹¹Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Habib El-Khoury, MD^1,2, Luca Bertamini, MD^1,2*, Jean-Baptiste Alberge, PhD^1,2,3*, David J. Lee, MD^1,3,4,5, Ciara Murphy^1,2*, Grace Fleming, BS^1,2*, Christian J. Cea-Curry, BS^1,2*, Maya I. Davis, BA^1,2*, Jacqueline Perry, MPH^1,2*, Elizabeth D. Lightbody, PhD^1,2,6, Dhananjay Sakrikar, PhD^7*, Derek Troske, BS^7*, David Barnidge, PhD^7*, Mark C. Perkins, PhD^8*, Stephen Harding, PhD⁸, Gad Getz, PhD^1,6,9*, Catherine R. Marinac, PhD^1,2,10 and Irene Ghobrial, MD^1,2,6

¹Harvard Medical School, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Broad Institute of MIT and Harvard, Cambridge, MA
⁴Department of Medicine, Massachusetts General Hospital, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
⁶Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
⁷The Binding Site Inc., Rochester, MN
⁸The Binding Site Inc., Birmingham, United Kingdom
⁹Center for Cancer Research, Massachusetts General Hospital, Boston, MA
¹⁰Harvard T.H. Chan School of Public Health, Boston, MA

Beatrice Fregonese, MPH^1*, Alexandra Dreyfuss, MD^2*, Jisun Lee^3*, Brandon S. Imber, MD³, Joachim Yahalom, MD³ and Carla Hajj, MD^3*

¹Memorial Sloan Kettering Cancer Center, New York City, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Ieuan Walker, MBBS, MSc, BSc, MRCP^1*, Venetia D'arcy, MBBS, BSc, MRCP^1*, Antonio Rodriguez Romera, BSc.^1*, Georgina Anderson, BSc, PhD^1*, Anna Aubareda, PhD^2*, James Roy, BSc, PhD.^1*, Garima Khandelwal^3*, William Wilson^4*, Evelyn Fitzsimons, BSc^5*, Daria Galas-Filipowicz^6*, Kane Foster, BSc.^3*, Rakesh Popat^3,7*, Karthik Ramasamy⁸, Matthew Streetly, MD⁹, Ceri Bygrave^10*, Reuben Benjamin, MD, PhD¹¹, Ruth M. de Tute^12*, Marquita Camilleri^13*, Selina J Chavda, MBBS, BSc, MRCP, FRCPATH^5*, Gavin Pang^14*, Tushhar Dadaga, BSc^14*, Sumaiya Kamora, BSc^14*, James Cavenagh, MD^15,16, Elizabeth H. Phillips^17*, Laura Clifton-Hadley, BSc, PhD^18*, Roger G Owen^19*, Javier Herrero, PhD^20*, Kwee Yong^21,22* and Michael A Chapman, PhD, MRCP, FRCPath¹

¹MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
²University of Cambridge, Cambridge, GBR
³Cancer Institute, University College London, London, United Kingdom
⁴UCL Cancer Trials Centre, London, United Kingdom
⁵Cancer Institute, Department of Haematology, University College London, London, United Kingdom
⁶Cancer Institute, Department of Haematology, UCL, London, United Kingdom
⁷University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁸Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁹Department of Haematology, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom
¹⁰Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
¹¹Department of Haematology, King’s College Hospital, London, United Kingdom
¹²Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom
¹³Haematology, Addenbrookes Hospital, Cambridge, United Kingdom
¹⁴Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
¹⁵Department of Haematology, Barts Health NHS Trust, London, United Kingdom
¹⁶Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
¹⁷Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
¹⁸Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
¹⁹St. James's University Hospital, Leeds, United Kingdom
²⁰Cancer Institute, Bill Lyons Informatics Centre, University College London, London, United Kingdom
²¹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²²Department of Haematology, University College Hospital, London, United Kingdom

Thorir Einarsson Long, MD, PhD^1,2,3*, Elias Eythorsson, MD, PhD^4*, Sæmundur Rögnvaldsson, MD^5,6*, Olafur Indridason, MD, MHS^7*, Runolfur Palsson, MD^6,8*, Sigrún Thorsteinsdóttir, MD, PhD^8,9, Ingigerdur S Sverrisdottir, MD^6,8,10*, Thor Aspelund, PhD^8*, Brynjar Vidarsson, MD⁶, Páll Torfi Onundarson, MD^6,8, Bjarni Agnarsson, MD^6,8*, Margrét Sigurdardóttir, MD^6*, Ingunn Thorsteinsdottir, MD^6*, Ísleifur Ólafsson, MD, PhD^6*, Asdis Rosa Thordardottir^11*, Asbjorn Jonsson, MD^6*, Gauti Kjartan Gislason, MSc^8*, Andri Olafsson^8*, Hlif Steingrimsdottir, MD^6*, Malin Hultcrantz, MD, PhD¹², Brian G.M. Durie, MD¹³, Stephen Harding, PhD¹⁴, Ola Landgren, MD¹⁵, Thorvardur Jon Love, MD, PhD^6,8* and Sigurdur Y Kristinsson, MD, PhD^6,8

¹Landspitali University Hospital, Reykjavik, Iceland
²Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
³Skåne University Hospital, Lund, Sweden
⁴Landspitali - The National University Hospital of Iceland, Reykjavík, AL, Iceland
⁵Faculty of Medicine, University of Iceland, Reykjavík, Iceland
⁶Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
⁷Landspítali-The National University Hospital of Iceland, Reykjavik, ISL
⁸Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁹Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
¹⁰Sahlgrenska University Hospital, Gothenburg, Sweden
¹¹University of Iceland, Reykjavik, ISL
¹²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
¹⁴The Binding Site Inc., Birmingham, United Kingdom
¹⁵Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Ali Abdelhay, md¹, Amir Mahmoud, MD^1*, Simrat Gill, MD^2*, Omar Al Ali, MD^3*, Mohamed Salah Mohamed, MD^3*, Anas Hashem, MD^3*, Ahmed Shehadah, MD^3*, Basant Eltaher, MD^4*, Suhib Fahmawi, MD^5*, Mariam Haji, MD^6* and Mariam Mostafa, MD^3*

¹Rochester General Hospital, Rochester, NY
²Division of Internal Medicine, Rochester General Hospital, Rochester, NY
³Rochester General Hospital, Rochester N.Y, NY
⁴Department if Hematology and Bone Marrow Transplant, Faculty of Medicine, Ain Shams University, Cairo, Egypt
⁵East Tennessee State University - Quillen College of Medicine, Johnson City, TN
⁶University of Missouri-Kansas City, Kansas city, MO

Syed Arsalan Ahmed Naqvi, MBBS^1*, Sarosh Fatima, M.B.B.S^2*, Noureen Asghar^3*, Hafsah Ijaz, M.B.B.S.^4*, Ahsan Ayaz, M.D.^5*, Huan He, Ph.D.^6*, Muhammad Husnain, MD^7*, Rajshekar Chakraborty, MD⁸, Irbaz Riaz, MD, MMSc⁹ and Mohammed A. Aljama, M.D.^10*

¹Division of Hematology and Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ
²Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
³Creighton University, Omaha, NE
⁴Nishtar Medical University, Multan, Pakistan
⁵Mayo Clinic, Phoenix, AZ
⁶Mayo Clinic, Rochester, MN
⁷University of Arizona Cancer Center, Division of Hematology and Medical Oncology, Tucson, AZ
⁸Hematology and Medical Oncology, Columbia University, Irving Medical Center, New York, NY
⁹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁰McMaster University, Hamilton, ON, Canada

Linda B. Baughn, Ph.D¹, Elizabeth S. Mearns, PharmD^2*, Michael Nixon, MSN, MPH^2*, Vivek S. Chopra, PhD^3*, Allicia Girvan, PhD^4*, R. Frank Cornell, MD⁴, Jayeta Saxena, PhD^5*, Bethany M. Slifko, MBA, MLS (ASCP)cm^5*, Jordan Clark, MPhil^5* and Shaji K Kumar, MD¹

¹Mayo Clinic, Rochester, MN
²Genentech, Inc., South San Francisco, CA
³Genentech, Inc., San Francisco, CA
⁴AbbVie, Inc., North Chicago, IL
⁵Diaceutics PLC, Belfast, United Kingdom

Faris Jamal Abu Za'nouneh, MD^1*, Obada Ababneh^2*, Carolina Schinke^3,4, Sharmilan Thanendrarajan, MD^3,4, Maurizio Zangari, MD^3,4,5, John D Shaughnessy Jr., PhD^6*, Fenghuang Zhan, MD, PhD⁴, Frits van Rhee³ and Samer Al Hadidi, MD, MSc^4,7

¹Faculty of Medicine, Jordan University Of Science and Technology, Irbid, GA, Jordan
²Jordan University Of Science and Technology, Irbid, JOR
³Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
⁵Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁶Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR
⁷Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Yanying Yu^1*, Xuemin Gao, MD^1*, Hao Zhao, MD^1*, Anan Li, MD^1*, Hao Cai^2*, Jun Feng, MD^1*, Lu Zhang, MD^1*, Xinxin Cao, MD^1* and Jian Li, MD¹

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
²Department of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College,Peking Union Medical College Hospital,, Beijing, China

Stephanie Scalia, MS^1*, Denis Toskic, BS^1*, Ping Zhou, MD, PhD^2*, Mahesh M Mansukhani, MD^3*, Lisa Lee, MD^4*, Sandy W. Wong, MD⁵, Sascha A. Tuchman, MD, MHS⁶, James E. Hoffman, MD^7*, Teresa Fogaren, NP^2*, Cindy Varga, MD^8*, Suzanne Lentzsch, MD, PhD^9* and Raymond Comenzo, MD²

¹John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
²Tufts Medical Center, Boston, MA
³Columbia University Medical Center, New York, NY
⁴Chao Family Comprehensive Cancer Center, UC Irvine, Orange, CA
⁵Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
⁶Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁷Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami
⁸Levine Cancer Institute, Charlotte, NC
⁹Medical Oncology, Columbia University Medical Center, New York, NY

Mohamed A Badawi, PhD^1*, Benjamin Engelhardt, PhD^2*, Jesus Badillo, PhD^2*, Ahmed Abbas Suleiman, PhD^2*, Leanne Lash Fleming, PhD^3*, Yan Luo, MD, PhD^3*, Jonathan L. Kaufman, MD⁴, Nizar Jacques Bahlis, MD⁵, Rajeev Menon, PhD^1* and Ahmed Hamed Salem, PhD, FCP¹

¹Clinical Pharmacology, AbbVie Inc., North Chicago, IL
²Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, IL, Germany
³AbbVie Inc., North Chicago, IL
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁵Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada

Malin Hultcrantz, MD, PhD¹, David Kleinman, MD^2*, Ravi Vij, MD³, Fernando Escalante, MD^4*, Nirali Kotowsky, MPH^5*, Jacopo Bitetti, MD^6*, Christine Mackay, PhD^5*, Natalie Boytsov, PhD^5*, Leena Camadoo-O'Byrne, MSc^7*, Guillaume Germain, MSc^8*, Mei Sheng Duh, ScD, MPH⁹, François Laliberté^10*, Malena Mahendran, MSc^11*, Ana Urosevic, MA^12* and Hans C. Lee, MD¹³

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY
³Washington University, St Louis, MO
⁴Hematology Department, University Hospital of León, León, Spain
⁵GSK, Upper Providence, PA
⁶GSK, Zug, Switzerland
⁷GSK, Stevenage, United Kingdom
⁸Groupe d’Analyse, Ltée, Montréal, QC, Canada
⁹Analysis Group, Inc., Boston, MA
¹⁰Groupe d’analyse, Ltée, Montréal, QC, Canada
¹¹Groupe d’Analyse, Ltée, Montreal, Canada
¹²Groupe d’Analyse, Ltée, Montreal, QC, Canada
¹³Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX